Patent Transfer and Assignment Agreement between The bankruptcy estate of XNK Therapeutics AB (publ) and NÖK Therapeutics Inc. Dated 23 May 2024 Contents APPENDICESPatent Transfer and Assignment Agreement • September 26th, 2024 • Nok Therapeutics, Inc.
A On 9 April 2024, XNK Therapeutics AB (publ), a company incorporated and registered in Sweden with corporate registration number 556894-6601 (“XNK”), entered into bankruptcy (Sw. konkurs) and the district court appointed Anders Svensson Clark, lawyer (Sw. advokat), as the bankruptcy trustee (Sw. konkursförvaltare).
